RESTRICTED STOCK UNIT AWARD AGREEMENT VIRPAX PHARMACEUTICALS, INC.Restricted Stock Unit Award Agreement • July 25th, 2022 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 25th, 2022 Company Industry JurisdictionThis Restricted Stock Unit Award Agreement (the “Agreement” or “Award Agreement”), dated as of the “Award Date” set forth in the attached Exhibit A, is entered into between Virpax Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Awardee”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENTNonqualified Stock Option Grant Agreement • July 25th, 2022 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 25th, 2022 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Virpax Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
INCENTIVE STOCK OPTION GRANT AGREEMENTIncentive Stock Option Grant Agreement • July 25th, 2022 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 25th, 2022 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Virpax Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
VIRPAX PHARMACEUTICALS, INC. RESTRICTED STOCK AWARD AGREEMENTRestricted Stock Award Agreement • July 25th, 2022 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 25th, 2022 Company Industry JurisdictionThis Restricted Stock Award Agreement (the “Agreement”), dated as of the “Award Date” set forth in the attached Exhibit A, is entered into between Virpax Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the individual identified in Exhibit A (the “Awardee”).